Key facts
- This page summarizes Xichen Lin's Form 4 filing for Structure Therapeutics Inc. (GPCR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Aug 2025, 17:00.
Xichen Lin - 01 Jul 2025 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)
- Reporting relationship
- CHIEF SCIENTIFIC OFFICER
- Issuer ticker
- GPCR
- Reported as of
- 01 Jul 2025
- Net transaction value
- -$87,823
- SEC form
- 4
- Accepted by SEC
- 20 Aug 2025, 17:00:11 UTC
- Prior SEC filing
- 18 Mar 2025
- Next SEC filing
- 05 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jun Yoon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Xichen Lin filed Form 4 for Structure Therapeutics Inc. (GPCR) on 20 Aug 2025.
Change
- Previous filing in this sequence was filed on 18 Mar 2025.
- Current net transaction value: -$87,823.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001962926
Primary reporting owner
Lin Xichen
- Relationship
- CHIEF SCIENTIFIC OFFICER
- Address
- C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO
- Signature
- /s/ Jun Yoon, Attorney-in-Fact
- Signature date
- 20 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GPCR
transaction
Ordinary Shares
Tax liability
- Transaction value
- $87,823
- Shares
- -12,846
- Change %
- -5.9%
- Price
- $6.84
- Shares after
- 204,327
- Date
- 01 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
Footnote F2
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.